News & Events about Bluebird Bio Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE PR Newswire NEW YORK, May 2, 2023 NEW YORK, May 2, 2023 /PRNewswire...
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
NEW YORK, April 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Ticker Report
2 months ago
bluebird bio (NASDAQ:BLUE Get Rating) and Harpoon Therapeutics (NASDAQ:HARP Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst ...
Ticker Report
4 months ago
bluebird bio, Inc. (NASDAQ:BLUE Get Rating) has earned a consensus rating of Hold from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy ...